ANI Pharmaceuticals, Inc.
S&P 600
$70.19
-1.78%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Moderate debt: debt-to-equity of 0.52.
- Comfortable interest cover: operating profit covers interest about 3.4 times.
- Return on equity is moderate at 13.1%.
- Net profit margin is 8.9%.
- Current assets comfortably cover current liabilities (current ratio 2.71).
!Watch-points
- Return on capital employed is on the lower side at 9.1%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.35
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Piotroski F-ScoreModerate
6 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$1.61B
Current Price$ 70.19
High / Low$ 99.39 / 69.58
Stock P/E15.291939
Book Value$ 27.25
Dividend Yield0%
ROCE9.14%
ROE13.12%
Debt to Equity0.52
Current Ratio2.71
P/B Ratio2.5188403
EPS$ 3.32
Debt$309.11M
PAT Margin8.87%
Cash PAT$169.75M
ICR3.41